The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-6-(2-Amino-1-(1H-indol-3-yl)ethyl)-3-(pyridin-3-yl)-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one ID: ALA5282634
Max Phase: Preclinical
Molecular Formula: C22H20N4OS
Molecular Weight: 388.50
Associated Items:
Names and Identifiers Canonical SMILES: NCC(c1c[nH]c2ccccc12)N1CCc2c(-c3cccnc3)csc2C1=O
Standard InChI: InChI=1S/C22H20N4OS/c23-10-20(17-12-25-19-6-2-1-5-15(17)19)26-9-7-16-18(13-28-21(16)22(26)27)14-4-3-8-24-11-14/h1-6,8,11-13,20,25H,7,9-10,23H2
Standard InChI Key: XSYKKVGKKRLWNG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
0.1831 -0.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1831 -0.9101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8951 -1.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6117 -0.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6071 -0.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8951 0.3314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3869 0.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8735 -0.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3942 -1.1561 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.6005 0.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0173 1.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2309 2.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0279 2.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6095 1.9817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4007 1.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8955 -2.1435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5306 -1.3237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2457 -0.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5306 -2.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2451 -2.5611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9985 -1.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5511 -0.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1399 0.0779 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3331 -0.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2519 -2.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0583 -2.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6096 -1.5959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3609 -0.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
5 4 2 0
5 6 1 0
1 6 1 0
5 7 1 0
7 8 2 0
8 9 1 0
4 9 1 0
10 7 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
3 16 2 0
2 17 1 0
17 18 1 0
17 19 1 0
19 20 1 0
21 18 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 18 2 0
21 25 1 0
26 25 2 0
27 26 1 0
28 27 2 0
22 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 388.50Molecular Weight (Monoisotopic): 388.1358AlogP: 3.99#Rotatable Bonds: 4Polar Surface Area: 75.01Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.67CX LogP: 2.74CX LogD: 1.45Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: -0.76
References 1. Tanaka Y, Kurasawa O, Yokota A, Klein MG, Saito B, Matsumoto S, Okaniwa M, Ambrus-Aikelin G, Uchiyama N, Morishita D, Kimura H, Imamura S.. (2020) New Series of Potent Allosteric Inhibitors of Deoxyhypusine Synthase., 11 (8.0): [PMID:34345355 ] [10.1021/acsmedchemlett.0c00331 ]